Cadila Healthcare’s formulations manufacturing facility located at SEZ, Ahmedabad has received an Establishment Inspection Report (EIR). The USFDA had conducted an inspection from March 25 to April 3, 2019. The EIR report has stated that the classification of the facility is ‘Voluntary Action Indicated (VAI)’.
Cadila Healthcare is an India-based pharmaceutical company. The company's subsidiaries include Zydus Wellness, Liva Pharmaceuticals, Biochem Pharmaceutical Industries, Zydus Technologies, German Remedies, Dialforhealth India, Dialforhealth Unity and Dialforhealth Greencross, among others.
